| Detected | Trial | Change |
|---|---|---|
| 2026-08-02 | NCT05271292 Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. |
overall status: Recruiting → Unknown |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04921527 | Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or… | Ovarian Cancer | Recruiting |
| NCT06947967 | Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With… | Lymphoma, T-Cell, Peripheral | Recruiting |
| NCT06497985 | A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR… | Colorectal Cancer | Recruiting |
| NCT07445295 | Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With… | Metastatic Pancreatic Ductal Adenocarcinoma | Not Yet Recruiting |
| Phase 2 | |||
| NCT06492915 | Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal… | Pancreatic Ductal Adenocarcinoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07129382 | A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to… | Plaque Psoriasis | Recruiting |
| Phase 1 | |||
| NCT05979155 | A Study of NWY001 in Subjects With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting |
| NCT06902350 | Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors | Neoplasms | Recruiting |
| NCT06245122 | A Study of CS23546 in Subjects With Advanced Tumors | Advanced Tumors | Recruiting |
| NCT07511010 | Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets | T2DM (Type 2 Diabetes Mellitus) | Not Yet Recruiting |
| NCT07583771 | A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma | Pancreatic Adenocarcinoma | Not Yet Recruiting |
| Not specified | |||
| NCT07412015 | Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets | T2DM (Type 2 Diabetes Mellitus) | Not Yet Recruiting |
| NCT07519265 | Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets | T2DM (Type 2 Diabetes Mellitus) | Not Yet Recruiting |
| NCT07580638 | Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes | T2DM (Type 2 Diabetes Mellitus) | Not Yet Recruiting |